作者: Sridhar Mani , David Sciortino , Brian Samuels , Rose Arrietta , Richard L. Schilsky
关键词:
摘要: Precis: UFT 300 mg/m2/day and leucovorin 90 mg/day could be administered safely to patients with advanced biliary cancer good performance status; however, this combination schedule of 28-day administration has no activity in disease.